Chairman provides $1.25M advance for working capital amid liquidity crisis
PLUR is trading near its 52-week low of $2 (1.0% above the low).
Summary
Pluri Inc. received a $1.25 million advance from its Chairman, Alexandre Weinstein, for working capital, providing a critical cash injection amidst its liquidity crisis. Concurrently, co-founder Doron Shorrer, an experienced financial professional, was appointed to the Board and will chair the Audit Committee.
Key Events · Financing and Capital Events · PLUR
-
$1.25M Advance from Chairman
Chairman Alexandre Weinstein's entity, Chutzpah Holdings LP, provided a $1.25 million advance to Pluri Inc. on June 16, 2026, for working capital and general corporate purposes. This advance will be credited against a future financing expected by August 14, 2026.
-
Director Not Re-elected
Mr. Eitan Ajchenbaum was not re-elected to the Board of Directors at the Annual Meeting on June 15, 2026, ceasing his roles as an independent director and Chairman of the Audit Committee.
-
Experienced Co-founder Appointed to Board
Mr. Doron Shorrer, a co-founder and experienced financial professional, was elected to the Board on June 19, 2026, to fill the vacancy. He has been appointed as Chairman of the Audit Committee and sole member of the Investment Committee.
Analysis · PLUR · Life Sciences
The $1.25 million advance from Chairman Alexandre Weinstein's entity provides immediate working capital for Pluri Inc., which is critical given the company's previously disclosed acute liquidity crisis and imminent debt maturity. This continued financial support from a key insider, especially while the stock trades near 52-week lows, signals strong confidence and helps extend the company's cash runway. Additionally, the appointment of co-founder Doron Shorrer, an experienced financial professional, to the Board and as Audit Committee Chairman, strengthens financial oversight at a crucial time.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 36.9% of the 1029 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.77%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLUR was trading at $2.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.8M. The 52-week trading range was $2.00 to $5.96. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.